OBJECTIVE
To evaluate the incidence, risk factors, and clinical outcomes associated with venous thromboembolism (VTE) in patients with gynecologic cancer treated with immune checkpoint inhibitors (ICI).
METHODS
This retrospective cohort study included patients with gynecologic malignancies treated with ICI at a singl...
Cassidy Abdeen, Jessica Sciuva, Reed M. O'Connor et al.· Gynecologic Oncology· 0 citations
It is suggested that digital inequities may contribute to site- and age-specific disparities in gynecologic cancer survival, underscoring the need to address barriers to digital access as part of efforts to improve cancer outcomes.
Julia Chalif, Laura M. Chambers, Caitlin E. Meade et al.· International Journal of Gyn...· 0 citations
In this cohort of CC patients treated with IO, approximately 39% and 55% of patients were categorized as high risk according to pre-treatment NRI and PNI, respectively, and high-risk PNI and NRI classifications were associated with differences in irAEs, IO response, and oncologic outcomes.
Julia Chalif, Molly A. Morton, Eric M. McLaughlin et al.· Gynecologic Oncology Reports· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.